Clinical Trials Sponsored by Hunan Mental Hospital

Total 4574 results

Central South University
Shanghai Mental Health Center; Capital Medical University; Nanjing Medical University and other collaborators

Completed

Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia (ACPIOS)

Schizophrenia

China
Central Mental Hospital

Completed

Cognitive Remediation Therapy Within a Secure Forensic Setting

Schizophrenia | Schizoaffective Disorder | Cognitive Deficits

Ireland
Xiangya Hospital of Central South University
Hunan Cancer Hospital; The Third Xiangya Hospital of Central South University; Hunan Provincial People's Hospital and other collaborators

Completed

Urine-DNA Biomarkers in Detecting Bladder Cancer

Bladder Cancer | Urine | Diagnosis | Biomarker

China
Central South University
Shanghai Mental Health Center; Capital Medical University; Guangzhou Mental Hospital and other collaborators

Completed

Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia

Schizophrenia

China
Hunan University
Central South University

Not yet recruiting

An Evaluation on a Mental Health Art Exhibition's Impact on Reducing Stigma

Mental Health Issue
The Third Xiangya Hospital of Central South University
Hunan Cancer Hospital; Hunan Provincial People's Hospital; Second Xiangya Hospital... and other collaborators

Completed

Thromboelastography Normal Reference Values in China Hunan Province

Coagulopathy | Blood Transfusion Complication

China
Xiangya Hospital of Central South University
Hunan Cancer Hospital; The Third Xiangya Hospital of Central South University; Hunan Provincial People's Hospital and other collaborators

Completed

Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC

High-Grade Upper Tract Urothelial Carcinoma

China
Henan Cancer Hospital
The First Affiliated Hospital of Zhengzhou University; Henan Provincial People... and other collaborators

Recruiting

Clinical Study on the Safety of Double and a Half Layered Esophagojejunal Anastomosis in Curative Gastrectomy

Surgery--Complications

China
Hunan Province Tumor Hospital
Xiangya Hospital of Central South University

Recruiting

The Efficacy and Safety of IBI363 in Solid Tumors. (Promise)

Advanced Solid Tumor

China
Second Xiangya Hospital of Central South University
Hunan Cancer Hospital

Completed

A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Extensive-stage Small Cell Lung Cancer

China
Hunan Cancer Hospital
Hunan Medical University General Hospital

Not yet recruiting

A Real-world Study of Inetetamab for First-line Treatment of MBC

Breast Cancer | Real-world Study
Hunan Cancer Hospital

Not yet recruiting

Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.

Breast Cancer | Endocrine Therapy | CDK4/6 Inhibitors | Subsequent Treatment
Hunan Cancer Hospital

Recruiting

Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients

Breast Neoplasms | Neoplastic Cells, Circulating | Chemotherapy Effect

China
Hunan Cancer Hospital

Completed

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC

Metastatic Colorectal Adenocarcinoma

China
Hunan Cancer Hospital

Completed

Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer

Colorectal Cancer

China
Hunan Cancer Hospital

Completed

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer

Metastatic Colorectal Adenocarcinoma

China
Hunan Cancer Hospital

Completed

Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer

Metastatic Colorectal Adenocarcinoma

China
Hunan Children's Hospital

Completed

End of Life Care in Neonatal Intensive Unite

Palliative Care

China
Hunan Cancer Hospital

Unknown

PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage

Lymphoma

China
Hunan Children's Hospital

Recruiting

Exosome microRNAs as Potential Biomarkers of Metabolic Bone Disease of Prematurity

Bone Diseases, Metabolic | Newborn | Exosomes

China
Hunan Cancer Hospital

Not yet recruiting

Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure

Melanoma
Hunan Cancer Hospital

Recruiting

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Herpesvirus 4, Human

China
Hunan Cancer Hospital

Recruiting

Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer

HR+/HER2- Breast Cancer

China
Hunan Cancer Hospital

Not yet recruiting

Research on Optimization and Evaluation of Oral Cancer Screening Methods

Oral Cancer
Hunan Cancer Hospital

Recruiting

Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma

Chemotherapy Effect | NK/T-cell Lymphoma of Nasal Cavity | Immune Checkpoint Inhibitor | Epigenetic Disorder

China
Hunan Cancer Hospital

Recruiting

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

Ovarian Cancer

China
Hunan Cancer Hospital

Completed

Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Hunan Cancer Hospital

Completed

Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer (ACTDNAGLT)

Metastatic Breast Cancer | Circulating Tumor DNA | Gene Abnormality
Hunan Cancer Hospital

Unknown

A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer

Ovarian Cancer

China
Hunan Cancer Hospital

Recruiting

A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC

Carcinoma, Non-Small-Cell Lung

China
Hunan Cancer Hospital

Recruiting

UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases

Brain Metastases | Capecitabine | Metastatic HER2 Negative Breast Carcinoma | UDT1

China
Hunan Cancer Hospital

Recruiting

AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer

Ovarian Cancer

China
Hunan Children's Hospital

Not yet recruiting

VOICE Study in China 'Towards a Partnership Between Parents of Very Premature Infants and Healthcare Professionals' (VOICE)

Infant ALL | Parents | Emotional Stress | Neonatal Intensive Care | Family Centered Care | Family Separation | Parents Support
Hunan Cancer Hospital

Completed

Real World Study on the Efficacy and Safety of Anti-HER2 Therapy

Breast Neoplasms | HER2-positive Breast Cancer

China
Hunan Children's Hospital

Completed

Analysis of Personality Characteristics and Psychological Capital Factors on the Leadership of Pediatric Clinical Nurses

Leadership | Pediatric Nursing

China
Hunan Cancer Hospital

Completed

Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer (ACTDNA)

Metastatic Breast Cancer | Circulating Tumor DNA | Gene Abnormality
Hunan Cancer Hospital
The Third Xiangya Hospital of Central South University

Not yet recruiting

Clinical Study on Nutrition Intervention in Patients With Esophageal and Gastric Cancer Treated With Chemotherapy

Nutrition Aspect of Cancer
Children's Hospital of Fudan University
Henan Provincial People's Hospital; Xiamen Children's Hospital; Hunan Children... and other collaborators

Completed

A Multicenter Survey of the Indications for Esophagogastroduodenoscopy (EGD)

Endoscopy | Digestive System Abnormalities

China
Hunan Cancer Hospital
Henan Cancer Hospital; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors

Non Small Cell Lung Cancer

China
Xiangya Hospital of Central South University
The Third Xiangya Hospital of Central South University; Hunan Provincial People... and other collaborators

Recruiting

Multicenter Cohort Study of AAV in Hunan of China

ANCA Associated Vasculitis

China
BeBetter Med Inc
Xiangya Hospital of Central South University; Hunan Cancer Hospital

Active, not recruiting

Phase I Study of BEBT-209 in Women With Advanced Breast Cancer

Advanced Breast Cancer

China
Hunan Province Tumor Hospital

Not yet recruiting

Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW (WUKONG-32-RW)

Non-small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Not yet recruiting

Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC (WUKONG-32)

Non-Small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Not yet recruiting

AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC (Apple)

Efficacy
Hunan Province Tumor Hospital

Recruiting

A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer

Advanced Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC

NSCLC

China
Hunan Province Tumor Hospital

Recruiting

Effect of Time-of-Day (ToD) for Immunochemotherapy on PFS in NSCLC (PACIFIC15)

Non-small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) Metastases

Non-Small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

Efficacy and Biomarker Explanation of IBI-323 + Bevacizumab Plus Platinum Based Chemotherapy on ALK-Rearranged NSCLC

Non Small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB

Non Small Cell Lung Cancer

China

Clinical Trials Sponsored by Hunan Mental Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations